154 related articles for article (PubMed ID: 37903864)
1. Longitudinal x-ray based lung function measurement for monitoring Nintedanib treatment response in a mouse model of lung fibrosis.
Khan A; Markus MA; Svetlove A; Hülsmann S; Alves F; Dullin C
Sci Rep; 2023 Oct; 13(1):18637. PubMed ID: 37903864
[TBL] [Abstract][Full Text] [Related]
2. Effects of nintedanib on the microvascular architecture in a lung fibrosis model.
Ackermann M; Kim YO; Wagner WL; Schuppan D; Valenzuela CD; Mentzer SJ; Kreuz S; Stiller D; Wollin L; Konerding MA
Angiogenesis; 2017 Aug; 20(3):359-372. PubMed ID: 28283856
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
4. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
5. A fully automated micro‑CT deep learning approach for precision preclinical investigation of lung fibrosis progression and response to therapy.
Buccardi M; Ferrini E; Pennati F; Vincenzi E; Ledda RE; Grandi A; Buseghin D; Villetti G; Sverzellati N; Aliverti A; Stellari FF
Respir Res; 2023 May; 24(1):126. PubMed ID: 37161569
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
7. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
9. Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator.
De Ruysscher D; Granton PV; Lieuwes NG; van Hoof S; Wollin L; Weynand B; Dingemans AM; Verhaegen F; Dubois L
Radiother Oncol; 2017 Sep; 124(3):482-487. PubMed ID: 28774597
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nintedanib is well-tolerated and delivers key pharmacokinetic parameters required to treat bleomycin-induced pulmonary fibrosis.
Surber MW; Beck S; Pham S; Marsden AT; Gandi SK; Baily J; McElroy MC
Pulm Pharmacol Ther; 2020 Aug; 63():101938. PubMed ID: 32841676
[TBL] [Abstract][Full Text] [Related]
11. Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis.
Chen WC; Chen NJ; Chen HP; Yu WK; Su VY; Chen H; Wu HH; Yang KY
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630825
[TBL] [Abstract][Full Text] [Related]
12. Simple low dose radiography allows precise lung volume assessment in mice.
Khan A; Markus A; Rittmann T; Albers J; Alves F; Hülsmann S; Dullin C
Sci Rep; 2021 Feb; 11(1):4163. PubMed ID: 33602964
[TBL] [Abstract][Full Text] [Related]
13. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
Wollin L; Distler JHW; Redente EF; Riches DWH; Stowasser S; Schlenker-Herceg R; Maher TM; Kolb M
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31285305
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model.
Principi L; Ferrini E; Ciccimarra R; Pagani L; Chinello C; Previtali P; Smith A; Villetti G; Zoboli M; Ravanetti F; Stellari FF; Magni F; Piga I
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901840
[TBL] [Abstract][Full Text] [Related]
15. Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis.
Hesse C; Beneke V; Konzok S; Diefenbach C; Bülow Sand JM; Rønnow SR; Karsdal MA; Jonigk D; Sewald K; Braun A; Leeming DJ; Wollin L
Respir Res; 2022 Aug; 23(1):201. PubMed ID: 35927669
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ; Hayes B; Alexander R; Datta A; Forty EJ; Mercer PF; Blanchard A; Chambers RC
Eur Respir J; 2013 Dec; 42(6):1633-45. PubMed ID: 23520313
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease.
Atanelishvili I; Akter T; Noguchi A; Vuyiv O; Wollin L; Silver RM; Bogatkevich GS
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):115-124. PubMed ID: 31573469
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
20. SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib.
Ravanetti F; Ferrini E; Ragionieri L; Khalajzeyqami Z; Nicastro M; Ridwan Y; Kleinjan A; Villetti G; Grandi A; Stellari FF
Sci Rep; 2021 Sep; 11(1):18513. PubMed ID: 34531421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
